PTX3 and type 2 diabetes mellitus: The authors concluded that, although the findings indicated potential genotype-specific responses in PTX3 regulation following weight loss, larger and longer-term studies are needed to clarify the role of APOA-II polymorphism in PTX3 modulation and its implications for inflammation in patients with T2DM [77].